What is Biora Therapeutics Inc?
, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 994.99K, and a P/E ratio of 0.6x.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.